Logo image of MYSZ

MY SIZE INC (MYSZ) Stock Fundamental Analysis

NASDAQ:MYSZ - Nasdaq - US62844N4060 - Common Stock - Currency: USD

1.28  +0.03 (+2.4%)

After market: 1.2996 +0.02 (+1.53%)

Fundamental Rating

2

MYSZ gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 283 industry peers in the Software industry. While MYSZ seems to be doing ok healthwise, there are quite some concerns on its profitability. MYSZ is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

MYSZ had negative earnings in the past year.
In the past year MYSZ has reported a negative cash flow from operations.
In the past 5 years MYSZ always reported negative net income.
MYSZ had a negative operating cash flow in each of the past 5 years.
MYSZ Yearly Net Income VS EBIT VS OCF VS FCFMYSZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

The Return On Assets of MYSZ (-46.11%) is worse than 83.75% of its industry peers.
MYSZ's Return On Equity of -66.93% is on the low side compared to the rest of the industry. MYSZ is outperformed by 73.85% of its industry peers.
Industry RankSector Rank
ROA -46.11%
ROE -66.93%
ROIC N/A
ROA(3y)-65.37%
ROA(5y)-90.51%
ROE(3y)-125.25%
ROE(5y)-153.85%
ROIC(3y)N/A
ROIC(5y)N/A
MYSZ Yearly ROA, ROE, ROICMYSZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 -400 600

1.3 Margins

MYSZ's Gross Margin of 37.72% is on the low side compared to the rest of the industry. MYSZ is outperformed by 76.68% of its industry peers.
MYSZ's Gross Margin has declined in the last couple of years.
MYSZ does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 37.72%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.17%
GM growth 5Y-9.6%
MYSZ Yearly Profit, Operating, Gross MarginsMYSZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K

More info and screens

4

2. Health

2.1 Basic Checks

MYSZ does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MYSZ has more shares outstanding
MYSZ has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, MYSZ has an improved debt to assets ratio.
MYSZ Yearly Shares OutstandingMYSZ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
MYSZ Yearly Total Debt VS Total AssetsMYSZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

Based on the Altman-Z score of -9.29, we must say that MYSZ is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -9.29, MYSZ is doing worse than 87.63% of the companies in the same industry.
A Debt/Equity ratio of 0.03 indicates that MYSZ is not too dependend on debt financing.
The Debt to Equity ratio of MYSZ (0.03) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z -9.29
ROIC/WACCN/A
WACC9.58%
MYSZ Yearly LT Debt VS Equity VS FCFMYSZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

A Current Ratio of 3.02 indicates that MYSZ has no problem at all paying its short term obligations.
With a decent Current ratio value of 3.02, MYSZ is doing good in the industry, outperforming 77.03% of the companies in the same industry.
MYSZ has a Quick Ratio of 2.05. This indicates that MYSZ is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of MYSZ (2.05) is better than 62.19% of its industry peers.
Industry RankSector Rank
Current Ratio 3.02
Quick Ratio 2.05
MYSZ Yearly Current Assets VS Current LiabilitesMYSZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

3

3. Growth

3.1 Past

MYSZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 72.11%, which is quite impressive.
MYSZ shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -27.08%.
Measured over the past years, MYSZ shows a very strong growth in Revenue. The Revenue has been growing by 165.15% on average per year.
EPS 1Y (TTM)72.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%73.07%
Revenue 1Y (TTM)-27.08%
Revenue growth 3Y297.97%
Revenue growth 5Y165.15%
Sales Q2Q%-50.44%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y33.17%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year12.88%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MYSZ Yearly Revenue VS EstimatesMYSZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
MYSZ Yearly EPS VS EstimatesMYSZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2023 2024 2025 -100 -200 -300

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

MYSZ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MYSZ. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MYSZ Price Earnings VS Forward Price EarningsMYSZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MYSZ Per share dataMYSZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2 -3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MYSZ!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MY SIZE INC

NASDAQ:MYSZ (8/11/2025, 8:00:01 PM)

After market: 1.2996 +0.02 (+1.53%)

1.28

+0.03 (+2.4%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)03-27 2025-03-27/amc
Earnings (Next)N/A N/A
Inst Owners0.68%
Inst Owner Change0.16%
Ins Owners3.54%
Ins Owner Change0%
Market Cap3.97M
Analysts82.86
Price Target3.06 (139.06%)
Short Float %1.46%
Short Ratio0.44
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.59
P/FCF N/A
P/OCF N/A
P/B 0.66
P/tB 0.77
EV/EBITDA N/A
EPS(TTM)-3.58
EYN/A
EPS(NY)-2.75
Fwd EYN/A
FCF(TTM)-0.95
FCFYN/A
OCF(TTM)-0.95
OCFYN/A
SpS2.18
BVpS1.94
TBVpS1.67
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -46.11%
ROE -66.93%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 37.72%
FCFM N/A
ROA(3y)-65.37%
ROA(5y)-90.51%
ROE(3y)-125.25%
ROE(5y)-153.85%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.17%
GM growth 5Y-9.6%
F-Score4
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.02
Quick Ratio 2.05
Altman-Z -9.29
F-Score4
WACC9.58%
ROIC/WACCN/A
Cap/Depr(3y)6.12%
Cap/Depr(5y)22.62%
Cap/Sales(3y)0.26%
Cap/Sales(5y)5.92%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)72.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%73.07%
EPS Next Y33.17%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-27.08%
Revenue growth 3Y297.97%
Revenue growth 5Y165.15%
Sales Q2Q%-50.44%
Revenue Next Year12.88%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y28.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y58.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y58.1%
OCF growth 3YN/A
OCF growth 5YN/A